Archive for August 2024
CMS Finalizes Expedited TCET Coverage Pathway
The Centers for Medicare & Medicaid Services (CMS) finalized a new Transitional Coverage for Emerging Technologies (TCET) Pathway to expedite Medicare coverage of some FDA-approved breakthrough products. Under this finalized pathway, eligible US Food and Drug Administration (FDA) designated breakthrough devices that fall within a Medicare benefit category can obtain national coverage for several years…
Read MoreFirst Drugs Subject to Inflation Reduction Act Price Provisions
The Centers for Medicare & Medicaid Services (CMS) announced recently the prices that they have set for the first 10 medications as an outcome of the Inflation Reduction Act’s drug provisions. For the first time, the law provides Medicare the ability to directly “negotiate” (in effect, set, as otherwise significant penalties are imposed) the prices…
Read MoreFTC HOLDS PUBLIC MEETING ON PBMs
The Federal Trade Commission (FTC) held a virtual open meeting on the heels of issuing its Interim Report on Pharmacy Benefit Managers (PBMs). A press release summarized the report’s findings. Members of the public and other stakeholders provided arguments for PBM reform at the virtual meeting, citing the many ramifications that PBM business practices have had on patient…
Read MoreTransPharm Preclinical Solutions: Pioneering Infectious Disease Research from Jackson, MI, with a Global Reach – MichBio Member Feature
On January 22nd, 2007, Pfizer Global Research and Development in Ann Arbor closed its doors, resulting in thousands of job losses. Just two days later, Dan Ross established TransPharm Preclinical Solutions. Ross’s motivations for starting the company were numerous, with the loss of his beloved job being a significant factor. Determined to continue working in…
Read More